Nuclear medicine (notice n° 65613)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02915cam a2200277zu 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | FRCYB88842970 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250107220010.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250107s2017 fr | o|||||0|0|||eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9782759821402 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | FRCYB88842970 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | FR-PaCSA |
Language of cataloging | en |
Transcribing agency | |
Description conventions | rda |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Zimmermann, Richard |
245 01 - TITLE STATEMENT | |
Title | Nuclear medicine |
Remainder of title | Radioactivity for diagnosis and therapy |
Statement of responsibility, etc. | ['Zimmermann, Richard'] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Name of producer, publisher, distributor, manufacturer | EDP Sciences |
Date of production, publication, distribution, manufacture, or copyright notice | 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | p. |
336 ## - CONTENT TYPE | |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type code | c |
Source | rdamdedia |
338 ## - CARRIER TYPE | |
Carrier type code | c |
Source | rdacarrier |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Nuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten years have seen the introduction of major technical breakthroughs which will considerably modify the landscape of cancer treatment.Once injected to the patient, the radiopharmaceutical drug aims at the tumour cell ? including metastases ? selectively, settles there, and emits radiation. Depending on the radiation type, the drug will either help identify the cells or destroy them. Applications are not limited to oncology; indeed, nuclear medicine has found interesting applications in cardiology and neurology as well. The new millennium saw the introduction of the Hybrid imaging technology PET/CT which combines the Positron Emission Tomography (PET) modality with conventional high quality x-ray imaging. It took another two years until PET could be combined with Magnetic Resonance Imaging (MRI) in the hybrid equipment PET/MR. New tracers (drugs for diagnosis) also came on the market with different diseases as targets, such as prostate cancer, neuroendocrine tumours, or Alzheimer's disease. But the recent introduction of radiotherapeutics in the treatment of cancer has brought major changes on the market, for they can be much more powerful and specific than chemotherapeutics or external radiation therapy. Combining radiodiagnostics to select positive responders to a treatment with efficient radiotherapeutics opens a highway for the development of theranostics, another word for personalized medicine. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties met by both physicians and patients when trying to access new technologies. This second edition shows how much progress has been made over the past ten years since the original book was published, and how much can be expected for patients within the next few years. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zimmermann, Richard |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Access method | Cyberlibris |
Uniform Resource Identifier | <a href="https://international.scholarvox.com/netsen/book/88842970">https://international.scholarvox.com/netsen/book/88842970</a> |
Electronic format type | text/html |
Host name |
Pas d'exemplaire disponible.
Réseaux sociaux